Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.

2区 医学 Q1 Medicine
Advances in Cancer Research Pub Date : 2023-01-01 Epub Date: 2022-07-28 DOI:10.1016/bs.acr.2022.06.002
Giang Le Minh, Mauricio J Reginato
{"title":"Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.","authors":"Giang Le Minh, Mauricio J Reginato","doi":"10.1016/bs.acr.2022.06.002","DOIUrl":null,"url":null,"abstract":"<p><p>Tumor growth and metastasis can be promoted by a small sub-population of cancer cells, termed cancer stem-like cells (CSCs). While CSCs possess capability in self-renewing and differentiating, the hierarchy of CSCs during tumor growth is highly plastic. This plasticity in CSCs fate and function can be regulated by signals from the tumor microenvironment. One emerging pathway in CSCs that connects the alteration in microenvironment and signaling network in cancer cells is the hexosamine biosynthetic pathway (HBP). The final product of HBP, UDP-N-acetylglucosamine (UDP-GlcNAc), is utilized for glycosylating of membrane and secreted proteins, but also nuclear and cytoplasmic proteins by the post-translational modification O-GlcNAcylation. O-GlcNAcylation and its enzyme, O-GlcNAc transferase (OGT), are upregulated in nearly all cancers and been linked to regulate many cancer cell phenotypes. Recent studies have begun to connect OGT and O-GlcNAcylation to regulation of CSCs. In this review, we will discuss the emerging role of OGT and O-GlcNAcylation in regulating fate and plasticity of CSCs, as well as the potential in targeting OGT/O-GlcNAcylation in CSCs.</p>","PeriodicalId":50875,"journal":{"name":"Advances in Cancer Research","volume":"157 ","pages":"195-228"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895886/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/bs.acr.2022.06.002","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Tumor growth and metastasis can be promoted by a small sub-population of cancer cells, termed cancer stem-like cells (CSCs). While CSCs possess capability in self-renewing and differentiating, the hierarchy of CSCs during tumor growth is highly plastic. This plasticity in CSCs fate and function can be regulated by signals from the tumor microenvironment. One emerging pathway in CSCs that connects the alteration in microenvironment and signaling network in cancer cells is the hexosamine biosynthetic pathway (HBP). The final product of HBP, UDP-N-acetylglucosamine (UDP-GlcNAc), is utilized for glycosylating of membrane and secreted proteins, but also nuclear and cytoplasmic proteins by the post-translational modification O-GlcNAcylation. O-GlcNAcylation and its enzyme, O-GlcNAc transferase (OGT), are upregulated in nearly all cancers and been linked to regulate many cancer cell phenotypes. Recent studies have begun to connect OGT and O-GlcNAcylation to regulation of CSCs. In this review, we will discuss the emerging role of OGT and O-GlcNAcylation in regulating fate and plasticity of CSCs, as well as the potential in targeting OGT/O-GlcNAcylation in CSCs.

O-GlcNAcylation 在癌症干细胞中的作用:连接营养传感与细胞可塑性。
肿瘤的生长和转移可由一小部分癌细胞亚群(称为癌症干样细胞(CSCs))促进。虽然癌干细胞具有自我更新和分化能力,但在肿瘤生长过程中,癌干细胞的分级具有高度可塑性。CSCs命运和功能的这种可塑性可受肿瘤微环境信号的调控。CSCs中连接微环境变化和癌细胞信号网络的一个新途径是六聚糖生物合成途径(HBP)。HBP 的最终产物--UDP-N-乙酰葡糖胺(UDP-GlcNAc)通过翻译后修饰 O-GlcNAcylation 被用于膜蛋白和分泌蛋白的糖基化,也可用于核蛋白和细胞质蛋白的糖基化。O-GlcNAcylation 及其酶--O-GlcNAc 转移酶(OGT)在几乎所有癌症中都会上调,并与许多癌细胞表型的调节有关。最近的研究开始将 OGT 和 O-GlcNAcylation 与 CSCs 的调控联系起来。在这篇综述中,我们将讨论 OGT 和 O-GlcNAcylation 在调控 CSCs 的命运和可塑性方面的新作用,以及靶向 CSCs 中 OGT/O-GlcNAcylation 的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Cancer Research
Advances in Cancer Research 医学-肿瘤学
CiteScore
10.00
自引率
0.00%
发文量
52
期刊介绍: Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. The first ACR volume came out in the year that Watson and Crick reported on the central dogma of biology, the DNA double helix. In the first 100 volumes are found many contributions by some of those who helped shape the revolution and who made many of the remarkable discoveries in cancer research that have developed from it.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信